Gilead Sciences (GILD) Revenue — Quarter Ended Sep 30, 2024
Gilead Sciences reported an increase in revenue for the third quarter. The company saw growth compared to both the prior quarter and the same period last year.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Gilead Sciences reported an increase in revenue for the third quarter. The company saw growth compared to both the prior quarter and the same period last year.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$7.5B
Revenue reported for this quarter.
Quarter-over-quarter
+8.5%
Change from the immediately preceding quarter.
Year-over-year
+7.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$28.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $7.1B | -3.7% |
| Mar 31, 2024 | $6.7B | +5.3% |
| Jun 30, 2024 | $7B | +5.4% |
| Sep 30, 2024 | $7.5B | +7.0% |
Revenue performance
Revenue rose sequentially, reflecting continued business momentum. The year-over-year improvement further underscores a positive trajectory.
Quarterly comparison
Compared to the immediately preceding quarter, revenue showed a notable increase. When measured against the same quarter one year earlier, revenue was also higher.
What to watch
Monitor whether the revenue gains in recent quarters can be sustained in the coming periods.